56 related articles for article (PubMed ID: 11900624)
21. Substance use histories in patients seeking treatment for controlled-release oxycodone dependence.
Potter JS; Hennessy G; Borrow JA; Greenfield SF; Weiss RD
Drug Alcohol Depend; 2004 Nov; 76(2):213-5. PubMed ID: 15488345
[TBL] [Abstract][Full Text] [Related]
22. [Admission status of alcohol and drug-dependent patients in "high threshold" access to withdrawal treatment].
Wagner HB; Schwoon DR; Lambert M; Krausz M
Psychiatr Prax; 1999 Jan; 26(1):25-8. PubMed ID: 10087573
[TBL] [Abstract][Full Text] [Related]
23. A randomized controlled trial of interim methadone maintenance.
Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of oral mucosal lesions in alcohol misusers in south London.
Harris CK; Warnakulasuriya KA; Cooper DJ; Peters TJ; Gelbier S
J Oral Pathol Med; 2004 May; 33(5):253-9. PubMed ID: 15078483
[TBL] [Abstract][Full Text] [Related]
25. Dissolution of a harm reduction track for opiate agonist treatment: longitudinal impact on treatment retention, substance use and service utilization.
Hartzler B; Cotton AJ; Calsyn DA; Guerra R; Gignoux E
Int J Drug Policy; 2010 Jan; 21(1):82-5. PubMed ID: 19278847
[TBL] [Abstract][Full Text] [Related]
26. [New possibilities in treatment and rehabilitation of alcohol-dependent patients--a catamnestic study on the efficiency of outpatient treatment programmes demonstrated by a model procedure].
Soyka M; Hasemann S; Scharfenberg CD; Löhnert B; Bottlender M
Nervenarzt; 2003 Mar; 74(3):226-34. PubMed ID: 12627237
[TBL] [Abstract][Full Text] [Related]
27. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.
Gossop M; Stewart D; Marsden J
Addiction; 2008 Jan; 103(1):119-25. PubMed ID: 18028521
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic reliability of the Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA).
Pierucci-Lagha A; Gelernter J; Feinn R; Cubells JF; Pearson D; Pollastri A; Farrer L; Kranzler HR
Drug Alcohol Depend; 2005 Dec; 80(3):303-12. PubMed ID: 15896927
[TBL] [Abstract][Full Text] [Related]
29. Trends in drop out, drug free discharge and rates of re-presentation: a retrospective cohort study of drug treatment clients in the North West of England.
Beynon CM; Bellis MA; McVeigh J
BMC Public Health; 2006 Aug; 6():205. PubMed ID: 16904004
[TBL] [Abstract][Full Text] [Related]
30. Patients who terminate OMT--how do they fare?
Clausen T; Åsland R; Kristensen Ø
Tidsskr Nor Laegeforen; 2014 Jun; 134(11):1146-50. PubMed ID: 24939781
[TBL] [Abstract][Full Text] [Related]
31. The Drinker's Check-up: 12-month outcomes of a controlled clinical trial of a stand-alone software program for problem drinkers.
Hester RK; Squires DD; Delaney HD
J Subst Abuse Treat; 2005 Mar; 28(2):159-69. PubMed ID: 15780546
[TBL] [Abstract][Full Text] [Related]
32. Individual and system influences on waiting time for substance abuse treatment.
Carr CJ; Xu J; Redko C; Lane DT; Rapp RC; Goris J; Carlson RG
J Subst Abuse Treat; 2008 Mar; 34(2):192-201. PubMed ID: 17512159
[TBL] [Abstract][Full Text] [Related]
33. Outcomes for substance user treatment in women: results from the Baltimore Drug and Alcohol Treatment Outcomes Study.
Johnson JL; Wiechelt SA; Ahmed AU; Schwartz RP
Subst Use Misuse; 2003; 38(11-13):1807-29. PubMed ID: 14582579
[TBL] [Abstract][Full Text] [Related]
34. The impact of terminating disability benefits for substance abusers on substance use and treatment participation.
Watkins KE; Podus D
Psychiatr Serv; 2000 Nov; 51(11):1371-2,1381. PubMed ID: 11058181
[No Abstract] [Full Text] [Related]
35. The wait on the nurses' shoulders.
Harlow W; Happell B; Brown G
Aust Nurs J; 2011 Jul; 19(1):48. PubMed ID: 21853691
[No Abstract] [Full Text] [Related]
36. Treating an opiate-dependent inpatient population: a one-year follow-up study of treatment completers and noncompleters.
Ghodse AH; Reynolds M; Baldacchino AM; Dunmore E; Byrne S; Oyefeso A; Clancy C; Crawford V
Addict Behav; 2002; 27(5):765-78. PubMed ID: 12201383
[TBL] [Abstract][Full Text] [Related]
37. Gender, waitlists, and outcomes for public-sector drug treatment.
Downey L; Rosengren DB; Donovan DM
J Subst Abuse Treat; 2003 Jul; 25(1):19-28. PubMed ID: 14512104
[TBL] [Abstract][Full Text] [Related]
38. Voluntary agencies dealing with drug and alcohol misusers: a comparison of three surveys conducted in London, Scotland, and Tasmania.
Easthope G; Lynch PP
Int J Addict; 1992 Dec; 27(12):1401-11. PubMed ID: 1452391
[TBL] [Abstract][Full Text] [Related]
39. Reporting practices of dropouts in psychological research using a wait-list control: current state and suggestions for improvement.
Cisler JM; Barnes AC; Farnsworth D; Sifers SK
Int J Methods Psychiatr Res; 2007; 16(1):34-42. PubMed ID: 17425246
[TBL] [Abstract][Full Text] [Related]
40. Wait times for publicly funded addiction and problem gambling treatment agencies in Ontario, Canada.
Pascoe RV; Rush B; Rotondi NK
BMC Health Serv Res; 2013 Nov; 13():483. PubMed ID: 24252217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
